Has USFDA banned imports from the Toansa plant of Ranbaxy in India?
Others answers (1)
On 27 January 2014 The U.S. Food and Drug Administration (USFDA) banned the import of products from Ranbaxy's Toansa plant in India. The ban was imposed on account of safety and quality concerns. Citing manufacturing norm violations, the US Food and Drug Administration prohibited Ranbaxy Laboratories from distributing drugs produced at the Toansa unit, including medicines made by the company's Ohm Laboratory's facility in New Jersey. However, this is the company's fourth plant to face regulatory action from the American health regulator after Mohali, Paonta Sahib and Dewas plants. Ranbaxy was started by Ranbir Singh and Gurbax Singh in 1937 as a distributor for a Japanese company Shionogi and it was acquired by Japanese Pharmaceutical Company Daiichi Sankyo in 2008. Ranbaxy exports its products to 125 countries with ground operations in 43 and manufacturing facilities in eight countries.
- Show More